DOI QR코드

DOI QR Code

A Case of Crescentic Glomerulonephritis with Coexisting Anti-Glomerular Basement Membrane Antibodies and Myeloperoxidase-Anti-Neutrophil Cytoplasmic Autoantibodies

항사구체기저막 항체 및 MPO-ANCA 양성인 초승달 사구체신염

  • Jung, Kyong Yeun (Department of Internal Medicine, Dankook University College of Medicine) ;
  • Go, Jai Hyang (Department of Pathology, Dankook University College of Medicine) ;
  • Cho, Jong Tae (Department of Internal Medicine, Dankook University College of Medicine)
  • 정경연 (단국대학교 의과대학 내과학교실) ;
  • 고재향 (단국대학교 의과대학 병리학교실) ;
  • 조종태 (단국대학교 의과대학 내과학교실)
  • Published : 2012.11.01

Abstract

Rapidly progressive glomerulonephritis (RPGN) is a clinical syndrome involving abrupt or insidious onset of hematuria, proteinuria, and anemia, and rapidly progressive renal failure. Crescentic glomerulonephritis is a histopathological term for RPGN showing extensive extracapillary proliferation, i.e., crescent formation. There are three major immunopathological categories of crescentic glomerulonephritis: anti-glomerular basement membrane (anti-GBM) antibody disease, immune complex-mediated, and pauci-immune (anti-neutrophil cytoplasmic autoantibody [ANCA]-positive). A small minority of all patients with glomerulonephritis develop crescentic glomerulonephritis. Anti-GBM antibodies and ANCA rarely coexist. There have been a few reports of dual positive crescentic glomerulonephritis with anti-GBM antibodies and ANCA in Korea. Here, we describe the case of a 73-year-old woman showing RPGN clinically and crescentic glomerulonephritis pathologically with coexisting anti-GBM antibodies and myeloperoxidase-ANCA.

급속진행성 사구체신염의 병리학적 진단인 초승달 사구체신염은 면역학적 발병기전에 따라 항사구체기저막 항체, 면역 복합체, 무면역침착(ANCA 양성) 질환 등의 세 가지로 분류할 수 있다. 그러나 이런 면역학적 발병기전이 중복되어 나타나는 경우가 있다. 특히 항사구체기저막 항체와 ANCA 모두 양성인 초승달 사구체신염은 매우 드문 경우라고 할 수 있다. 저자들은 항사구체기저막 항체와 MPO-ANCA 모두 양성인 초승달 사구체신염 1예를 경험하였기에 최근까지 보고되고 있는 두 가지 항체 모두 양성인 초승달 사구체신염의 임상소견과 특징 및 예후에 관한 문헌고찰과 함께 보고하는 바이다.

Keywords

References

  1. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 1988;11:449-464.
  2. Jayne DR, Marshall PD, Jones SJ, Lockwood CM. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990;37:965-970. https://doi.org/10.1038/ki.1990.72
  3. Lee KH, Lee DR, Kim KH, et al. A case of anti-glomerular basement membrane antibody associated crescentic glomerulonephritis with positive antineutrophilic cytoplasmic antibody. Korean J Nephrol 1999;18:656-660.
  4. Ryu JI, Cho KH, Heo SW, et al. A case of rapidly progressive glomerulonephitis associated with anti-glomerular basement membrane antibody and p-antineutrophilic cytoplasmic antibody. Korean J Nephrol 2002;21:691-696.
  5. Black RM. Rapidly progressive glomerulonephritis. In: Black RM, ed. Rose & Black's Clinical Problems in Nephrology. 1st ed. Boston: Little, Brown and Company, 1996:352-357.
  6. Lewis JB, Neilson EG. Glomerular diseases. In: Fauci A, Braunwald E, Kasper D, et al, ed. Harrison's Principles of Internal Medicine. 17th ed. Vol. 2. New York: McGraw-Hill Companies, Inc., 2008:1786-1790.
  7. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003;63:1164-1177. https://doi.org/10.1046/j.1523-1755.2003.00843.x
  8. Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase- ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 2005;46:253-262. https://doi.org/10.1053/j.ajkd.2005.05.003
  9. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004;66:1535-1540. https://doi.org/10.1111/j.1523-1755.2004.00917.x
  10. Lindic J, Vizjak A, Ferluga D, et al. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Ther Apher Dial 2009;13:278-281. https://doi.org/10.1111/j.1744-9987.2009.00724.x